Memantine Hydrochloride

Memantine Hydrochloride is an NMDA receptor antagonist primarily used in the treatment of moderate to severe Alzheimer’s disease.

Therapeutic Categories
Anti-Dementia drug
Pharmacopoeia
USP, In-house
CAS No.
[ 41100-52-1 ]
Stage
C - Commercial

Memantine Hydrochloride is an NMDA receptor antagonist primarily used in the treatment of moderate to severe Alzheimers disease. It acts by modulating excessive glutamatergic neurotransmission and reducing NMDA receptor-mediated calcium influx, thereby helping to limit neuronal excitotoxicity. Memantine HCl is used to support cognitive and functional performance in patients with Alzheimer's dementia.

1,3-Dimethyladamantane (1,3-DMA) is manufactured in-house and used as the starting material for the synthesis of Memantine Hydrochloride.

Cooperate with Olpha

Media

For media relations and partnerships

Business

For distributors and business partners

Social Initiatives

For social causes and potential projects

Careers

For open positions and career opportunties

Attention!

Information on prescription medications should only be viewed by healthcare professionals.

Are you a health care worker?